Atrial Fibrillation Market Size, Analysis, Trends and Forecasts Till 2020: Hexa Research

The increasing incidences of atrial fibrillation, strokes due to blood clots and brain damages are the major factors driving the global atrial fibrillation market. Furthermore, the rising geriatric population base globally suffering from various heart diseases is also a factor propelling the atrial fibrillation market. Some of the other drivers for the global atrial fibrillation market include the rising prevalence of diseases caused by lifestyle habits such as excessive alcohol consumption and smoking. As atrial fibrillation patients have risk of blood clot formation and occurrence of strokes, patients are also treated with anti clotting and blood thinning medications. The increased demand for atrial fibrillation and minimally invasive procedures is a direct consequence of rapidly increasing incidences of heart failures, congenital heart diseases and coronary artery diseases all over the world. In young patients, sometimes heart rhythm control cannot be maintained through medication or cardioversion, then radiofrequency ablation can be attempted to control the heart rhythm. The technological advancements in the field of radiofrequency ablation such as the introduction of remotely obtained computed tomography has also increased the growth of the atrial fibrillation market. The risk of atrial fibrillation disease increases with age. As stated by WHO, 8% of people who are over the age of 80 suffer from some kind of atrial fibrillation. The increasing incidences of atrial fibrillation triggering diseases globally, such as obesity, pneumonia, pulmonary embolus, high blood pressure, hyperthyroidism and mitral stenosis is the factor expected to further fuel the atrial fibrillation market over the forecast period.

View More About Atrial Fibrillation Market With TOC:

The global atrial fibrillation market is segmented on the basis of pharmacological procedures and non pharmacological procedures. The pharmacological treatments involve anti coagulant drugs and anti arrhythmic drugs. The non pharmacological procedures are the therapies which does not include drugs for the diagnosis of diseases. The non pharmacological procedure includes diagnosis through procedures such as electric cardioversion, maze surgery and catheter ablation. The surgical catheter ablation dominates the atrial fibrillation market owing to an extremely high success rate in most arrhythmias. The surgical catheter ablation includes several procedures. The most commonly used procedure in catheter ablation includes microwave catheter ablation and radiofrequency catheter ablation. Their increased application is a consequence of faster recovery and the reduced size of cardiac incision.

View More, Visit: